Haemonetics (HAE) Non-Current Deferred Tax Liability (2010 - 2026)
Haemonetics (HAE) posted quarterly Non-Current Deferred Tax Liability of $38.0 million for Q1 2026, down 72.81% year-over-year from $140.0 million in Q1 2025, and down 32.03% quarter-over-quarter from $56.0 million in Q4 2025.
Haemonetics (HAE) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Haemonetics' Non-Current Deferred Tax Liability history runs 17 years deep, the most recent figure standing at $38.0 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 72.81% year-over-year to $38.0 million; the TTM figure through Mar 2026 stood at $38.0 million (down 72.81% YoY), while the FY2026 annual figure was $38.0 million, down 72.81% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $38.0 million, down from $56.0 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $140.0 million in Q1 2025, with the low at $26.1 million in Q1 2022.
- The 5-year median for Non-Current Deferred Tax Liability is $48.1 million (2022), against an average of $52.1 million.
- The sharpest annual moves came in 2022 and 2026: Non-Current Deferred Tax Liability surged 166.57% in 2022, then tumbled 72.81% in 2026.
- Haemonetics' Non-Current Deferred Tax Liability stood at $40.2 million in 2022, then soared by 55.03% to $62.2 million in 2023, then fell by 1.28% to $61.5 million in 2024, then fell by 8.9% to $56.0 million in 2025, then sank by 32.03% to $38.0 million in 2026.
- Business Quant data shows HAE's Non-Current Deferred Tax Liability at $38.0 million in Q1 2026, $56.0 million in Q4 2025, and $58.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 38.69 Mn |
| Jun 27, 2026 | 38.69 Mn |
| Mar 28, 2026 | 38.05 Mn |
| Mar 28, 2026 | 38.05 Mn |
| Dec 27, 2025 | 55.98 Mn |
| Dec 27, 2025 | 55.98 Mn |
| Sep 27, 2025 | 58.20 Mn |
| Sep 27, 2025 | 58.20 Mn |
| Jun 28, 2025 | 59.49 Mn |
| Jun 28, 2025 | 59.49 Mn |
| Mar 29, 2025 | 139.96 Mn |
| Mar 29, 2025 | 139.96 Mn |
| Dec 28, 2024 | 61.45 Mn |
| Dec 28, 2024 | 61.45 Mn |
| Sep 28, 2024 | 62.89 Mn |
| Sep 28, 2024 | 62.89 Mn |
| Jun 29, 2024 | 64.79 Mn |
| Jun 29, 2024 | 64.79 Mn |
| Mar 30, 2024 | 62.64 Mn |
| Mar 30, 2024 | 62.64 Mn |